On-Demand Webinar | Maximizing CAR-T Cell Yields with Perfusion & Stirred-Tank Bioreactors

Join our webinar with UCL experts to explore how advanced perfusion techniques and stirred-tank bioreactors can overcome CAR-T manufacturing limitations. Learn strategies for achieving higher cell densities, seamless scale-up, and reduced process development costs.


What You Will Learn:

  1. Enable consistent expansion of CAR-T cells in stirred-tank bioreactors  

  2. Increase yield up to five-fold using perfusion-based process intensification and Design of Experiments (DOE)

  3. Optimize conditions, reduce variability, and improve phenotype with serum-free media 

Please Complete the Form

Complete Form to Register

Meet Our Experts

Julia Hengst

Product Manager, Immune Cell Media

Julia Hengst is Product Manager for Immune Cell Media at Sartorius. She joined the company as an External Collaborations Manager, where she built and led partnerships through scientific collaborations around immune and stem cell therapies. 

She holds a PhD in immunology and has years of experience in product management for biomedical research and cell and gene therapy clinical applications.

Dr. Qasim Rafiq

Professor of Cell and Gene Therapy Bioprocess Engineering, Vice Dean (Health) in Faculty of Engineering at UCL

Dr. Qasim Rafiq is Vice Dean for Health in the Faculty of Engineering and a Professor in Bioprocess Engineering at University College London. He is a multidisciplinary engineer focusing on the bioprocessing, automation, and biomanufacturing of cell and gene-based therapies.